101 related articles for article (PubMed ID: 8482843)
1. Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8.
Sekimata M; Tanabe M; Sarai A; Yamamoto J; Kariyone A; Nakauchi H; Egawa K; Takiguchi M
J Immunol; 1993 May; 150(10):4416-26. PubMed ID: 8482843
[TBL] [Abstract][Full Text] [Related]
2. The allorecognition of H-2Kb-specific CD4-CD8- T cell hybridomas is influenced by the substitution at residue 256 of MHC class I molecules.
Tanabe M; Minami M; Kano K; Takiguchi M
J Immunol; 1990 Sep; 145(6):1968-73. PubMed ID: 2118159
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain.
Tanabe M; Sekimata M; Ferrone S; Takiguchi M
J Immunol; 1992 May; 148(10):3202-9. PubMed ID: 1374450
[TBL] [Abstract][Full Text] [Related]
5. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
[TBL] [Abstract][Full Text] [Related]
6. Beta-chain broadens range of CD8 recognition for MHC class I molecule.
Karaki S; Tanabe M; Nakauchi H; Takiguchi M
J Immunol; 1992 Sep; 149(5):1613-8. PubMed ID: 1506684
[TBL] [Abstract][Full Text] [Related]
7. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
[TBL] [Abstract][Full Text] [Related]
8. Selective reactivity of CD8-independent T lymphocytes to a cytotoxic T lymphocyte-selected H-2Kb mutant altered at position 222 in the alpha 3 domain.
Shepherd SE; Sun R; Nathenson SG; Sheil JM
Eur J Immunol; 1992 Mar; 22(3):647-53. PubMed ID: 1547812
[TBL] [Abstract][Full Text] [Related]
9. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8.
Salter RD; Norment AM; Chen BP; Clayberger C; Krensky AM; Littman DR; Parham P
Nature; 1989 Mar; 338(6213):345-7. PubMed ID: 2784196
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
Barber LD; Lechler RI
J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
[TBL] [Abstract][Full Text] [Related]
12. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
13. Location of the epitope for an anti-CD8alpha antibody 53.6.7 which enhances CD8alpha-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation.
Devine L; Hodsdon ME; Daniels MA; Jameson SC; Kavathas PB
Immunol Lett; 2004 May; 93(2-3):123-30. PubMed ID: 15158607
[TBL] [Abstract][Full Text] [Related]
14. Allo-class I-reactive CD4-CD8- T cell hybridomas recognize the conformational change of class I molecule resulting from the exchange of the alpha 3 domain.
Yamamoto J; Tanabe M; Minami M; Kano K; Takiguchi M
Eur J Immunol; 1989 Oct; 19(10):1861-5. PubMed ID: 2479566
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K.
Feuerbach D; Etteldorf S; Ebenau-Jehle C; Abastado JP; Madden D; Burgert HG
J Immunol; 1994 Aug; 153(4):1626-36. PubMed ID: 8046235
[TBL] [Abstract][Full Text] [Related]
16. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
[TBL] [Abstract][Full Text] [Related]
17. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes.
Potter TA; Rajan TV; Dick RF; Bluestone JA
Nature; 1989 Jan; 337(6202):73-5. PubMed ID: 2462676
[TBL] [Abstract][Full Text] [Related]
18. Orientation of the Ig domains of CD8 alpha beta relative to MHC class I.
Devine L; Sun J; Barr MR; Kavathas PB
J Immunol; 1999 Jan; 162(2):846-51. PubMed ID: 9916707
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide.
Ribaudo RK; Margulies DH
J Immunol; 1995 Oct; 155(7):3481-93. PubMed ID: 7561043
[TBL] [Abstract][Full Text] [Related]
20. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
Solheim JC; Carreno BM; Smith JD; Gorka J; Myers NB; Wen Z; Martinko JM; Lee DR; Hansen TH
J Immunol; 1993 Nov; 151(10):5387-97. PubMed ID: 7693810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
